# Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors

> **NCT02684318** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Poveda, Andrés, M.D.** · enrollment: 100 (estimated)

## Conditions studied

- Advanced Cancer
- Ovarian Cancer
- Endometrial Cancer
- Breast Cancer

## Interventions

- **DRUG:** PM01183 + olaparib

## Key facts

- **NCT ID:** NCT02684318
- **Lead sponsor:** Poveda, Andrés, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2019-07
- **Final completion:** 2019-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-06-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02684318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02684318, "Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT02684318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*